Register Cart 0

Generic placeholder image

Current Gene Therapy

Editor-in-Chief

ISSN (Print): 1566-5232
ISSN (Online): 1875-5631

Back Subscribe

Biography

Meet Our Editor

Author(s): Lung-Ji Chang

Volume 16, Issue 5, 2016

Page: [294 - 295] Pages: 2

DOI: 10.2174/156652321605170209193444

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

11

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Synthesis and Stereochemistry-Activity Relationship of Chiral Thiourea Derivatives as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry

Acute Graft-Versus-Host Disease-Challenge for a Broader Application of Allogeneic Hematopoietic Cell Transplantation
Current Stem Cell Research & Therapy

Phytochemicals as Adjunctive with Conventional Anticancer Therapies
Current Pharmaceutical Design

Xanthohumol: A Metabolite with Promising Anti-Neoplastic Potential
Anti-Cancer Agents in Medicinal Chemistry

Pharmacogenetic Aspects of Drug Metabolizing Enzymes in Busulfan Based Conditioning Prior to Allogenic Hematopoietic Stem Cell Transplantation in Children
Current Drug Metabolism

Repurposing Drugs for Cancer Prevention
Current Topics in Medicinal Chemistry

Polysaccharide Colloids as Smart Vehicles in Cancer Therapy
Current Pharmaceutical Design

The Role of Stress Proteins in Prostate Cancer
Current Genomics

Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer
Anti-Cancer Agents in Medicinal Chemistry

T Cell Redirecting Therapies for Cancer Treatment
Current Cancer Drug Targets

Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin
Recent Patents on Anti-Cancer Drug Discovery

Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists
Current Topics in Medicinal Chemistry

MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer
Current Cancer Drug Targets

Development of Novel Protein Scaffolds as Alternatives to Whole Antibodies for Imaging and Therapy: Status on Discovery Research and Clinical Validation
Current Pharmaceutical Biotechnology

Clinical Experience with Antiangiogenic Therapy in Leukemia
Current Cancer Drug Targets

Flavonoids: Prospective Drug Candidates
Mini-Reviews in Medicinal Chemistry

Imaging Virus-Associated Cancer
Current Pharmaceutical Design

Collateral Damage Control in Cancer Therapy: Defining the Stem Identity in Gliomas
Current Pharmaceutical Design

Overview of Naphthalimide Analogs as Anticancer Agents
Current Medicinal Chemistry

The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on CD34+/CD38+ and CD34+/CD38- AML Progenitor Cells
Current Cancer Drug Targets

© 2025 Bentham Science Publishers | Privacy Policy